Open the map

Edwards LifesciencesEW

Medtech & devices · NYSE · USA

$84.24
Down 1.8% todayClose

Up 0.6% this year but −7.2% since June 26, behind the life science sector at +10.7%. Edwards Lifesciences is one of 11 companies Sectivia maps in Medtech & devices.

Market cap
$47.6B
This year
+0.6%
1 year
+11.8%
P/E
47.4
P/S
7.3
P/B
4.5

Price vs the life science sector

since Jun 26EWLife science sector, equal weight
Edwards Lifesciences (EW) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. EW: −7.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOctOct 8EW −7.2%Sector +10.7% Edwards Lifesciences (EW) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. EW: −7.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8EW−7.2%Sector+10.7%

Supply chain

No suppliers or customers are mapped for Edwards Lifesciences yet.

See the life science value chain →

About Edwards Lifesciences

Heart valves, delivered by catheter as with TAVR or implanted surgically.

Theme exposure

MedtechStructural heartHeart valves

Products

  • Transcatheter heart valves (TAVR)
  • Surgical valves
  • Structural heart

Competitors

Risks

  • Competition in TAVR
  • Growth slowdown

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Intuitive SurgicalISRG+0.2%MedtronicMDT+2.6%StrykerSYK+0.6%Boston ScientificBSX+1.1%Becton DickinsonBDX+1.4%ResMedRMD+0.3%GE HealthCareGEHC−0.7%Zimmer BiometZBH+0.4%

Compare EW

Side by side with the largest companies in the same segment.

EW vs ISRGEW vs MDTEW vs SYKEW vs BSXEW vs BDXEW vs RMD

See where Edwards Lifesciences sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →